论文部分内容阅读
慢性粒细胞白血病(以下简称慢粒)是白血病中比较多见的类型。Spiers 认为慢粒占白血病的15%,Moloney 报告慢粒170例,占同期白血病1102例的15.4%,西欧,英美其它组,慢粒占成人白血病的15～20%。近年来急性白血病的治疗已取得显著进展,在儿童中尤其突出。相比之下,慢粒治疗进展缓慢。自1902年放射治疗开始,到1953年马利兰问世,尽管几乎所有病人初次治疗都有效,但生存期的延长很有限。1924年 Minot 报告未经治疗的慢粒病人中数生存期自诊断之日算起为19个月,自出现症状算起为31个月。Monfardini 等报告178例,经20年观察(1948～1967)
Chronic myeloid leukemia (hereinafter referred to as CML) is a more common type of leukemia. According to Spiers, Cough accounts for 15% of leukemias, Moloney reports 170 cases of CML, accounting for 15.4% of the 1102 cases of leukemia in the same period, and 15-20% of adult leukemias in western and other Anglo-American countries. In recent years, the treatment of acute leukemia has made significant progress, especially in children. In contrast, CML has been slow to progress. Since the beginning of radiation therapy in 1902 and to Maryland in 1953, the survival period has been limited, although almost all patients are treated for the first time. In 1924 Minot reported that the median survival of untreated chronic myeloid patients was 19 months from the date of diagnosis and 31 months from the onset of symptoms. Monfardini and other reports 178 cases, after 20 years of observation (1948 ~ 1967)